Kane Biotech, a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, has developed and patented a new bone tissue regenerating ...

For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy. Traditional small molecules often struggle to bind to proteins with flat ...

Cyprumed and MSD signed a nonexclusive license and option agreement to develop oral formulations of MSD’s peptides using Cyprumed’s innovative drug delivery technology. MSD gains nonexclusive global ...

The use of monoclonal antibodies has changed the treatment of several immune-mediated inflammatory diseases, including psoriasis. However, these large proteins must be administered by injection.

ABP-0904 and ABP-0918 also increased titanium hardness by more than 50% compared with the uncoated metal. The company intends to pursue commercial development in the medical industry where biofilm ...

Scientists have developed stable orally available cyclic peptides with a much higher bioavailability than current ones, virtually creating a generation of drugs that can target previously untreatable ...